Search

Search Results

• 

  Interferon gamma-inducible protein 16 (IFI16) and anti-IFI16 antibodies in primary Sjögren’s syndrome: findings in serum and minor salivary glands

  A. Alunno, V. Caneparo, F. Carubbi, O. Bistoni, S. Caterbi, M. Gariglio, E. Bartoloni, S. Landolfo, R. Gerli

  85-90

  09-02-2016

  https://doi.org/10.4081/reumatismo.2015.839

  2895

  PDF: 1329
• 

  Secondary hemophagocytic lymphohistiocytosis possibly induced by interferon beta-1a therapy.

  C. Cosso, R. Cosso, M.A. Cimmino

  253-255

  18-12-2013

  https://doi.org/10.4081/reumatismo.2013.253

  3264

  PDF: 917
• 

  Evaluation of Th9 lymphocytes in peripheral blood of rheumatoid arthritis patients and correlation with anti-tumor necrosis factor therapy: results from an in vitro pivotal study

  R. Talotta, A. Berzi, F. Atzeni, D. Dell'Acqua, P. Sarzi Puttini, D. Trabattoni

  83-89

  09-09-2016

  https://doi.org/10.4081/reumatismo.2016.875

  2197

  PDF: 1029

  IL RUOLO DEI LINFOCITI TH9 NELL'ARTRITE REUMATOIDE E NELLA RISPOSTA AL TRATTAMENTO CON INFLIXIMAB.: 649

• PO:18:271 | Managing concomitant sle and psoriasis: the role of anifrolumab in a clinical case Angela Carenza¹, Liliana Dinoia², Sergio De Gioia², Federica Gatti¹, Teresa Caferri¹, Lucia Cristiana Colaprico¹, Angelica Napoletano¹, Giuseppe Lopalco¹, Florenzo Iannone¹. | ¹Rheumatology Unit, University of Bari, Department of Precision and Regenerative Medicine, Jonian area ^DiMePRe-J, Bari, Italy; ²Azienda Sanitaria Locale di Taranto, presidio ospedaliero SS. Annunziata, Unità Operativa di Reumatologia, Taranto, Italy.

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2047

  366
• 

  Ex vivo and in vitro production of pro-inflammatory cytokines in Blau syndrome

  P. Galozzi, O. Negm, E. Greco, N. Alkhattabi, A. Gava, P. Sfriso, L. Fairclough, I. Todd, P. Tighe, L. Punzi

  277-284

  31-03-2015

  https://doi.org/10.4081/reumatismo.2014.772

  2460

  PDF: 1135

• PO:14:203 | Impact of anifrolumab on depressive symptoms in systemic lupus erythematosus: results from a single-centre prospective observational study Luca Moroni¹, Biancamaria Venerandi¹, Maria Cilona¹, Anna Vivona¹, Gabriele Gallina¹, Giovanni Benanti¹, Enrica Bozzolo¹, Giuseppe Ramirez¹, Marco Matucci-Cerinic¹, Lorenzo Dagna¹. | ¹U.O. di Immunologia, Reumatologia, Allergologia e Malattie Rare - IRCCS Ospedale San Raffaele, Milano, Italy.

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2032

  182

• Combined interferon a2b and cyclosporin A in the treatment of chronic hepatitis C: controlled trial - Reply

  A. Donvito, A. Crisanti, F. Bellisai, M. Galeazzi

  128-129

  https://doi.org/10.4081/reumatismo.2005.128

  940

  PDF: 757
• 

  Measurement of serum interferon alpha in Egyptian patients with systemic lupus erythematosus and evaluation of its effect on disease activity: a case-control study

  A. Fayed, M.M. El Menyawi, M. Ghanema, O. Shaker, R. Elgohary

  145-153

  19-11-2020

  https://doi.org/10.4081/reumatismo.2020.1308

  1581

  PDF: 830

• PO:25:079 | Anifrolumab in refractory dermatomyositis: a case report Chiara Calabrese¹, Corrado Campochiaro^1|2, Giacomo De Luca ^1|2, Veronica Batani¹, Marco Matucci-Cerinic^1|2, Lorenzo Dagna ^1|2 | ¹Dipartimento di Reumatologia e Scienze Mediche, ASST Centro Specialistico Ortopedico Traumatologico Gaetano Pini-CTO Milano; ²Università degli Studi di Milano, Dipartimento di Fisiopatologia Medico-Chirurgica e Trapianti, Milano, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2190

  190

• PO:10:149 | Efficacy of anifrolumab in a case of systemic lupus erythematosus with pulmonary involvement Fabio Brandolino¹, Giulia Pazzola¹, Luca Ronzoni³, Andreina Teresa Manfredi^1|2, Carlo Salvarani^1|2 | ¹SC Reumatologia, IRCCS Arcispedale Santa Maria Nuova, AUSL Reggio Emilia; ²Università di Modena e Reggio Emilia, Scuola di specializzazione in Reumatologia, Modena; ³SC Malattie dell'Apparato Respiratorio, IRCCS Arcispedale Santa Maria Nuova, AUSL Reggio Emilia, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2146

  274

• PO:16:227 | Anifrolumab for Systemic Lupus Erythematosus: Preliminary Safety and Efficacy Findings from the Italian Experience Paola Bizioli^1|2, Chiara Orlandi^1|2, Claudia Barison^1|2, Cesare Tomasi³, Alessia Caproli¹, Silvia Piantoni^1|2, Simona Signorini⁴, Emirena Garrafa⁴, Cecilia Nalli¹, Micol Frassi¹, Ilaria Cavazzana^1|2, Micaela Fredi^1|2, Franco Franceschini^1|2 | ¹Rheumatology and Clinical Immunology Unit - ERN ReCONNET, ASST Spedali Civili of Brescia, Italy; ²Department of Clinical and Experimental Sciences, University of Brescia, Italy; ³Department of Clinical and Experimental Sciences, University of Brescia, Italy; ⁴Laboratory of Clinical Chemistry, Department of Molecular and Translational Medicine, University of Brescia, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2333

  101

• Blocking TNF in vitro with infliximab determines the inhibition of expansion and interferon gamma production of Vγ9/Vδ2 T lymphocytes from patients with active rheumatoid arthritis. A role in the susceptibility to tuberculosis?

  A.R. Giardina, A. Accardo-Palumbo, F. Ciccia, A. Ferrante, A. Principato, R. Impastato, G. Triolo

  21-26

  https://doi.org/10.4081/reumatismo.2009.21

  1615

  PDF: 1239
• 

  Sudden improvement of alopecia universalis and psoriatic arthritis while receiving upadacitinib: a case-based review

  Carlo Perricone, Roberto Dal Pozzolo, Giacomo Cafaro, Santina Calvacchi, Lorenza Bruno, Francesco Tromby, Anna Colangelo, Roberto Gerli, Elena Bartoloni

  25-10-2024

  https://doi.org/10.4081/reumatismo.2024.1685

  2677

  PDF: 791

• PO:18:276 | Use of anifrolumab in the treatment of difficult-to-treat manifestations in systemic lupus erythematosus Antonella Grimaldi¹, Giuseppe Alessandrini², Laura Quarta¹, Maria Rita Ricciardi¹, Daniela Costanza¹, Clara Minerba¹, Eugenio Quarta¹ | ¹UOC Reumatologia Verona; ²Specialista Dermatologo in Libera Professione, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2170

  248

• PO:16:235 | Anifrolumab in systemic lupus erythematosus: real-life experience of a single-center cohort Filippo Vesentini¹, Luca Iaccarino¹, Federico Arru², Greta Hulej¹, Anna Giorgia Osele¹, Noemi Merra¹, Davide Ragno¹, Andrea Doria¹, Margherita Zen¹ | ¹UOC Reumatologia, Dipartimento di Medicina DIMED, Università degli Studi di Padova; ²UO Medicina, ASL 3 Nuoro, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2162

  193